Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
T. Kageyama, S. Tanaka, K. Etori, K. Hattori, K. Miyachi, T. Kasuya, T. Iwamoto, K. Ikeda, H. Igari, K. Yokote, H. Nakajima
The paper identifies immunological features, including B cell frequencies and CD8+ T cell activation, that correlate with antibody response strength to the BNT162b2 mRNA vaccine.
bioRxiv · Jun 21, 2021Immunology